Tenascin-C Is Increased in Inflammatory Bowel Disease and Is Associated with response to Infliximab Therapy

Table 1

Characteristics of included subjects.

	NC	UC	CD	value
Age median (years)	39.0 (33.0, 46.0)	38.0 (31.3, 53.0)	35.0 (24.5, 50.5)	0.357
Gender, M/F	30/21	26/14	53/38	0.755
TNC median (ng/ml)	37.1 (27.7, 54.6)	74.1 (42.6, 102.1)	59.2 (44.0, 80.9)	<0.001

NCs, normal controls; UC, ulcerative colitis; CD, Crohn’s disease.